TrialThe lancet. Gastroenterology & hepatology2026

Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

Gideon M Hirschfield et al.PubMed ↗Publisher ↗

No numbers read from the abstract.